PrimeRFP SCOUT · Federal Contract Recompete Brief

75N98026P00592Outsourcing PCAS and epidurals for patients — Quva Pharma, Inc

Quva Pharma, Inc holds $411K across 10 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the May 25, 2027 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Olao

Awarding office

Quva Pharma, Inc

Recipient

May 25, 2027

PoP end

$110K

Obligated

$110K

Potential

325412

NAICS

6505

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Quva Pharma, Inc — $90

Contract facts

NONE

Contract number75N98026P00592

AgencyNational Institutes Of Health Olao

Awarding officeNational Institutes Of Health Olao

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentQuva Pharma, Inc

CAGE7VLA4

UEIMUABDCZXMLG4

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Place of performanceBETHESDA MD

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startMay 26, 2026

PoP end (current)May 25, 2027

Obligated$110K

Current value$110K

Potential value$110K

OUTSOURCING PCAS AND EPIDURALS FOR PATIENTS CARE FROM QUVA PHARMA, INC. is a federal NONE award for National Institutes Of Health Olao held by Quva Pharma, Inc. Estimated value $110K ($110K obligated). Current period of performance ends May 25, 2027. Last award drew 1 bidder. Place of performance: BETHESDA MD.

OUTSOURCING PCAS AND EPIDURALS FOR PATIENTS CARE FROM QUVA PHARMA, INC.

Recompete timing

Public

● Expiring in 260 days

Current PoP ends May 25, 2027 (260 days remaining). Agencies typically plan 12–18 months ahead — at 8.5 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Quva Pharma, Inc — $411K obligated across 10 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$459K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N98026P00592?

75N98026P00592 (Outsourcing PCAS and epidurals for patients) is a National Institutes Of Health Olao award with a potential value of $110K, currently held by Quva Pharma, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N98026P00592?

National Institutes Of Health Olao awarded 75N98026P00592 to Quva Pharma, Inc (potential $110K).

Who is the incumbent on 75N98026P00592?

Quva Pharma, Inc is the incumbent with $411K across 10 related awards in SCOUT’s public footprint. The current period of performance ends May 25, 2027.

When does Quva Pharma, Inc’s 75N98026P00592 come up for recompete?

SCOUT tracks a period-of-performance end of May 25, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N98026P00592 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 30, 2026 · refreshed monthlyLatest procurement action May 29, 2026